The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Pneumonia Testing-Global Market Insights and Sales Trends 2024
Synopsis
Pneumonia is a complicated infection of the lower respiratory tract. It may start on or after an upper respiratory tract infection.
The global Pneumonia Testing market size is expected to reach US$ 1469.7 million by 2029, growing at a CAGR of 7.4% from 2023 to 2029. The market is mainly driven by the significant applications of Pneumonia Testing in various end use industries. The expanding demands from the Hospital, Clinic, Medical Center and Other, are propelling Pneumonia Testing market. Consumables, one of the segments analysed in this report, is projected to record % CAGR and reach US$ million by the end of the analysis period. Growth in the Analyzers segment is estimated at % CAGR for the next seven-year period.
The rising popularity of point-of-care (POC) testing as one of the primary growth factors for this market.
Report Objectives
This report provides market insight on the different segments, by players, by Type, by Application. Market size and forecast (2018-2029) has been provided in the report. The primary objectives of this report are to provide 1) global market size and forecasts, growth rates, market dynamics, industry structure and developments, market situation, trends; 2) global market share and ranking by company; 3) comprehensive presentation of the global market for Pneumonia Testing, with both quantitative and qualitative analysis through detailed segmentation; 4) detailed value chain analysis and review of growth factors essential for the existing market players and new entrants; 5) emerging opportunities in the market and the future impact of major drivers and restraints of the market.
Key Features of The Study:
This report provides in-depth analysis of the global Pneumonia Testing market, and provides market size (US$ million) and CAGR for the forecast period (2023-2029), considering 2022 as the base year.
This report profiles key players in the global Pneumonia Testing market based on the following parameters - company details (found date, headquarters, manufacturing bases), products portfolio, Pneumonia Testing sales data, market share and ranking.
This report elucidates potential market opportunities across different segments and explains attractive investment proposition matrices for this market.
This report illustrates key insights about market drivers, restraints, opportunities, market trends, regional outlook.
Key companies of Pneumonia Testing covered in this report include Abbott Molecular, Fast-track diagnostics, Becton, Dickenson and Company (BD), Roche Molecular Diagnostics, Thermo Fisher Scientific, AdvanDx, Abbott, Beckman Coulter and Bio-Rad, etc.
The global Pneumonia Testing market report caters to various stakeholders in this industry including investors, suppliers, product players, distributors, new entrants, and financial analysts.
Market Segmentation
Company Profiles:
Abbott Molecular
Fast-track diagnostics
Becton, Dickenson and Company (BD)
Roche Molecular Diagnostics
Thermo Fisher Scientific
AdvanDx
Abbott
Beckman Coulter
Bio-Rad
Cepheid
Concile
Diamedix
DiaSorin
Eiken Chemical
Global Pneumonia Testing market, by region:
North America (U.S., Canada, Mexico)
Europe (Germany, France, UK, Italy, etc.)
Asia Pacific (China, Japan, South Korea, Southeast Asia, India, etc.)
South America (Brazil, etc.)
Middle East and Africa (Turkey, GCC Countries, Africa, etc.)
Global Pneumonia Testing market, Segment by Type:
Consumables
Analyzers
Global Pneumonia Testing market, by Application
Hospital
Clinic
Medical Center
Other
Core Chapters
Chapter One: Introduces the report scope of the report, executive summary of global and regional market size and CAGR for the history and forecast period (2018-2023, 2024-2029). It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter Two: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter Three: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter Four: Detailed analysis of Pneumonia Testing companies’ competitive landscape, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter Five: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product introduction, revenue, recent development, etc.
Chapter Six, Seven, Eight, Nine and Ten: North America, Europe, Asia Pacific, Latin America, Middle East & Africa, revenue by country.
Chapter Eleven: this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter Twelve: Research Finding/Conclusion
Pneumonia is a complicated infection of the lower respiratory tract. It may start on or after an upper respiratory tract infection.
The global Pneumonia Testing market size is expected to reach US$ 1469.7 million by 2029, growing at a CAGR of 7.4% from 2023 to 2029. The market is mainly driven by the significant applications of Pneumonia Testing in various end use industries. The expanding demands from the Hospital, Clinic, Medical Center and Other, are propelling Pneumonia Testing market. Consumables, one of the segments analysed in this report, is projected to record % CAGR and reach US$ million by the end of the analysis period. Growth in the Analyzers segment is estimated at % CAGR for the next seven-year period.
The rising popularity of point-of-care (POC) testing as one of the primary growth factors for this market.
Report Objectives
This report provides market insight on the different segments, by players, by Type, by Application. Market size and forecast (2018-2029) has been provided in the report. The primary objectives of this report are to provide 1) global market size and forecasts, growth rates, market dynamics, industry structure and developments, market situation, trends; 2) global market share and ranking by company; 3) comprehensive presentation of the global market for Pneumonia Testing, with both quantitative and qualitative analysis through detailed segmentation; 4) detailed value chain analysis and review of growth factors essential for the existing market players and new entrants; 5) emerging opportunities in the market and the future impact of major drivers and restraints of the market.
Key Features of The Study:
This report provides in-depth analysis of the global Pneumonia Testing market, and provides market size (US$ million) and CAGR for the forecast period (2023-2029), considering 2022 as the base year.
This report profiles key players in the global Pneumonia Testing market based on the following parameters - company details (found date, headquarters, manufacturing bases), products portfolio, Pneumonia Testing sales data, market share and ranking.
This report elucidates potential market opportunities across different segments and explains attractive investment proposition matrices for this market.
This report illustrates key insights about market drivers, restraints, opportunities, market trends, regional outlook.
Key companies of Pneumonia Testing covered in this report include Abbott Molecular, Fast-track diagnostics, Becton, Dickenson and Company (BD), Roche Molecular Diagnostics, Thermo Fisher Scientific, AdvanDx, Abbott, Beckman Coulter and Bio-Rad, etc.
The global Pneumonia Testing market report caters to various stakeholders in this industry including investors, suppliers, product players, distributors, new entrants, and financial analysts.
Market Segmentation
Company Profiles:
Abbott Molecular
Fast-track diagnostics
Becton, Dickenson and Company (BD)
Roche Molecular Diagnostics
Thermo Fisher Scientific
AdvanDx
Abbott
Beckman Coulter
Bio-Rad
Cepheid
Concile
Diamedix
DiaSorin
Eiken Chemical
Global Pneumonia Testing market, by region:
North America (U.S., Canada, Mexico)
Europe (Germany, France, UK, Italy, etc.)
Asia Pacific (China, Japan, South Korea, Southeast Asia, India, etc.)
South America (Brazil, etc.)
Middle East and Africa (Turkey, GCC Countries, Africa, etc.)
Global Pneumonia Testing market, Segment by Type:
Consumables
Analyzers
Global Pneumonia Testing market, by Application
Hospital
Clinic
Medical Center
Other
Core Chapters
Chapter One: Introduces the report scope of the report, executive summary of global and regional market size and CAGR for the history and forecast period (2018-2023, 2024-2029). It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter Two: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter Three: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter Four: Detailed analysis of Pneumonia Testing companies’ competitive landscape, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter Five: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product introduction, revenue, recent development, etc.
Chapter Six, Seven, Eight, Nine and Ten: North America, Europe, Asia Pacific, Latin America, Middle East & Africa, revenue by country.
Chapter Eleven: this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter Twelve: Research Finding/Conclusion
Index1 Market Overview of Pneumonia Testing
1.1 Pneumonia Testing Market Overview
1.1.1 Pneumonia Testing Product Scope
1.1.2 Pneumonia Testing Market Status and Outlook
1.2 Global Pneumonia Testing Market Size Overview by Region 2018 VS 2022 VS 2029
1.3 Global Pneumonia Testing Market Size by Region (2018-2029)
1.4 Global Pneumonia Testing Historic Market Size by Region (2018-2023)
1.5 Global Pneumonia Testing Market Size Forecast by Region (2024-2029)
1.6 Key Regions, Pneumonia Testing Market Size (2018-2029)
1.6.1 North America Pneumonia Testing Market Size (2018-2029)
1.6.2 Europe Pneumonia Testing Market Size (2018-2029)
1.6.3 Asia-Pacific Pneumonia Testing Market Size (2018-2029)
1.6.4 Latin America Pneumonia Testing Market Size (2018-2029)
1.6.5 Middle East & Africa Pneumonia Testing Market Size (2018-2029)
2 Pneumonia Testing Market by Type
2.1 Introduction
2.1.1 Consumables
2.1.2 Analyzers
2.2 Global Pneumonia Testing Market Size by Type: 2018 VS 2022 VS 2029
2.2.1 Global Pneumonia Testing Historic Market Size by Type (2018-2023)
2.2.2 Global Pneumonia Testing Forecasted Market Size by Type (2024-2029)
2.3 Key Regions Market Size by Type
2.3.1 North America Pneumonia Testing Revenue Breakdown by Type (2018-2029)
2.3.2 Europe Pneumonia Testing Revenue Breakdown by Type (2018-2029)
2.3.3 Asia-Pacific Pneumonia Testing Revenue Breakdown by Type (2018-2029)
2.3.4 Latin America Pneumonia Testing Revenue Breakdown by Type (2018-2029)
2.3.5 Middle East and Africa Pneumonia Testing Revenue Breakdown by Type (2018-2029)
3 Pneumonia Testing Market Overview by Application
3.1 Introduction
3.1.1 Hospital
3.1.2 Clinic
3.1.3 Medical Center
3.1.4 Other
3.2 Global Pneumonia Testing Market Size by Application: 2018 VS 2022 VS 2029
3.2.1 Global Pneumonia Testing Historic Market Size by Application (2018-2023)
3.2.2 Global Pneumonia Testing Forecasted Market Size by Application (2024-2029)
3.3 Key Regions Market Size by Application
3.3.1 North America Pneumonia Testing Revenue Breakdown by Application (2018-2029)
3.3.2 Europe Pneumonia Testing Revenue Breakdown by Application (2018-2029)
3.3.3 Asia-Pacific Pneumonia Testing Revenue Breakdown by Application (2018-2029)
3.3.4 Latin America Pneumonia Testing Revenue Breakdown by Application (2018-2029)
3.3.5 Middle East and Africa Pneumonia Testing Revenue Breakdown by Application (2018-2029)
4 Pneumonia Testing Competition Analysis by Players
4.1 Global Pneumonia Testing Market Size by Players (2018-2023)
4.2 Global Top Players by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Pneumonia Testing as of 2022)
4.3 Date of Key Players Enter into Pneumonia Testing Market
4.4 Global Top Players Pneumonia Testing Headquarters and Area Served
4.5 Key Players Pneumonia Testing Product Solution and Service
4.6 Competitive Status
4.6.1 Pneumonia Testing Market Concentration Rate
4.6.2 Mergers & Acquisitions, Expansion Plans
5 Company (Top Players) Profiles
5.1 Abbott Molecular
5.1.1 Abbott Molecular Profile
5.1.2 Abbott Molecular Main Business
5.1.3 Abbott Molecular Pneumonia Testing Products, Services and Solutions
5.1.4 Abbott Molecular Pneumonia Testing Revenue (US$ Million) & (2018-2023)
5.1.5 Abbott Molecular Recent Developments
5.2 Fast-track diagnostics
5.2.1 Fast-track diagnostics Profile
5.2.2 Fast-track diagnostics Main Business
5.2.3 Fast-track diagnostics Pneumonia Testing Products, Services and Solutions
5.2.4 Fast-track diagnostics Pneumonia Testing Revenue (US$ Million) & (2018-2023)
5.2.5 Fast-track diagnostics Recent Developments
5.3 Becton, Dickenson and Company (BD)
5.3.1 Becton, Dickenson and Company (BD) Profile
5.3.2 Becton, Dickenson and Company (BD) Main Business
5.3.3 Becton, Dickenson and Company (BD) Pneumonia Testing Products, Services and Solutions
5.3.4 Becton, Dickenson and Company (BD) Pneumonia Testing Revenue (US$ Million) & (2018-2023)
5.3.5 Roche Molecular Diagnostics Recent Developments
5.4 Roche Molecular Diagnostics
5.4.1 Roche Molecular Diagnostics Profile
5.4.2 Roche Molecular Diagnostics Main Business
5.4.3 Roche Molecular Diagnostics Pneumonia Testing Products, Services and Solutions
5.4.4 Roche Molecular Diagnostics Pneumonia Testing Revenue (US$ Million) & (2018-2023)
5.4.5 Roche Molecular Diagnostics Recent Developments
5.5 Thermo Fisher Scientific
5.5.1 Thermo Fisher Scientific Profile
5.5.2 Thermo Fisher Scientific Main Business
5.5.3 Thermo Fisher Scientific Pneumonia Testing Products, Services and Solutions
5.5.4 Thermo Fisher Scientific Pneumonia Testing Revenue (US$ Million) & (2018-2023)
5.5.5 Thermo Fisher Scientific Recent Developments
5.6 AdvanDx
5.6.1 AdvanDx Profile
5.6.2 AdvanDx Main Business
5.6.3 AdvanDx Pneumonia Testing Products, Services and Solutions
5.6.4 AdvanDx Pneumonia Testing Revenue (US$ Million) & (2018-2023)
5.6.5 AdvanDx Recent Developments
5.7 Abbott
5.7.1 Abbott Profile
5.7.2 Abbott Main Business
5.7.3 Abbott Pneumonia Testing Products, Services and Solutions
5.7.4 Abbott Pneumonia Testing Revenue (US$ Million) & (2018-2023)
5.7.5 Abbott Recent Developments
5.8 Beckman Coulter
5.8.1 Beckman Coulter Profile
5.8.2 Beckman Coulter Main Business
5.8.3 Beckman Coulter Pneumonia Testing Products, Services and Solutions
5.8.4 Beckman Coulter Pneumonia Testing Revenue (US$ Million) & (2018-2023)
5.8.5 Beckman Coulter Recent Developments
5.9 Bio-Rad
5.9.1 Bio-Rad Profile
5.9.2 Bio-Rad Main Business
5.9.3 Bio-Rad Pneumonia Testing Products, Services and Solutions
5.9.4 Bio-Rad Pneumonia Testing Revenue (US$ Million) & (2018-2023)
5.9.5 Bio-Rad Recent Developments
5.10 Cepheid
5.10.1 Cepheid Profile
5.10.2 Cepheid Main Business
5.10.3 Cepheid Pneumonia Testing Products, Services and Solutions
5.10.4 Cepheid Pneumonia Testing Revenue (US$ Million) & (2018-2023)
5.10.5 Cepheid Recent Developments
5.11 Concile
5.11.1 Concile Profile
5.11.2 Concile Main Business
5.11.3 Concile Pneumonia Testing Products, Services and Solutions
5.11.4 Concile Pneumonia Testing Revenue (US$ Million) & (2018-2023)
5.11.5 Concile Recent Developments
5.12 Diamedix
5.12.1 Diamedix Profile
5.12.2 Diamedix Main Business
5.12.3 Diamedix Pneumonia Testing Products, Services and Solutions
5.12.4 Diamedix Pneumonia Testing Revenue (US$ Million) & (2018-2023)
5.12.5 Diamedix Recent Developments
5.13 DiaSorin
5.13.1 DiaSorin Profile
5.13.2 DiaSorin Main Business
5.13.3 DiaSorin Pneumonia Testing Products, Services and Solutions
5.13.4 DiaSorin Pneumonia Testing Revenue (US$ Million) & (2018-2023)
5.13.5 DiaSorin Recent Developments
5.14 Eiken Chemical
5.14.1 Eiken Chemical Profile
5.14.2 Eiken Chemical Main Business
5.14.3 Eiken Chemical Pneumonia Testing Products, Services and Solutions
5.14.4 Eiken Chemical Pneumonia Testing Revenue (US$ Million) & (2018-2023)
5.14.5 Eiken Chemical Recent Developments
6 North America
6.1 North America Pneumonia Testing Market Size by Country (2018-2029)
6.2 U.S.
6.3 Canada
7 Europe
7.1 Europe Pneumonia Testing Market Size by Country (2018-2029)
7.2 Germany
7.3 France
7.4 U.K.
7.5 Italy
7.6 Russia
7.7 Nordic Countries
7.8 Rest of Europe
8 Asia-Pacific
8.1 Asia-Pacific Pneumonia Testing Market Size by Region (2018-2029)
8.2 China
8.3 Japan
8.4 South Korea
8.5 Southeast Asia
8.6 India
8.7 Australia
8.8 Rest of Asia-Pacific
9 Latin America
9.1 Latin America Pneumonia Testing Market Size by Country (2018-2029)
9.2 Mexico
9.3 Brazil
9.4 Rest of Latin America
10 Middle East & Africa
10.1 Middle East & Africa Pneumonia Testing Market Size by Country (2018-2029)
10.2 Turkey
10.3 Saudi Arabia
10.4 UAE
10.5 Rest of Middle East & Africa
11 Pneumonia Testing Market Dynamics
11.1 Pneumonia Testing Industry Trends
11.2 Pneumonia Testing Market Drivers
11.3 Pneumonia Testing Market Challenges
11.4 Pneumonia Testing Market Restraints
12 Research Finding /Conclusion
13 Methodology and Data Source
13.1 Methodology/Research Approach
13.1.1 Research Programs/Design
13.1.2 Market Size Estimation
13.1.3 Market Breakdown and Data Triangulation
13.2 Data Source
13.2.1 Secondary Sources
13.2.2 Primary Sources
13.3 Disclaimer
13.4 Author List
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
